Search results
Jump to navigation
Jump to search
- ...n="2"| Comparison!!rowspan="2"| Outcome!!colspan="2"|Rates!! rowspan="2"|[[Relative risk ratio]]!!rowspan="2"|Comment24 KB (3,451 words) - 22:02, 5 April 2015
- ! !! Patients!!Intervention / duration!!Outcome!![[Relative risk ratio]]23 KB (3,173 words) - 08:48, 7 August 2014
- ...00 mg/day||Placebo|| venous thromboembolism at 37 months|| 4.8%|| 6.5%|| [[relative risk ratio]] = 0.74 (95% [[confidence interval|CI]]: 0.52 to 1.05; P=0.09)29 KB (3,995 words) - 11:45, 2 February 2023
- In a [[randomized controlled trial]], the [[relative risk ratio]] of [[fidaxomicin]], as compared to [[vancomycin]], for recurrence of C. d In a [[randomized controlled trial]], the [[relative risk ratio]] of [[fidaxomicin]], as compared to [[vancomycin]], for recurrence of C. d46 KB (6,252 words) - 17:10, 31 October 2013
- ...ized controlled trial]] of adults with community-acquired pneumonia, the [[relative risk ratio]] of [[prednisone]] 50 mg daily for 7 days, as compared to [[placebo]], red22 KB (2,899 words) - 14:57, 31 January 2015
- ...[[randomized controlled trial]]s of patients with mild hypertension, the [[relative risk ratio]] of [[pharmacotherapy]], as compared to [[placebo]], for mortality was 0.856 KB (7,418 words) - 15:13, 5 November 2013
- * Relative risk ratio55 KB (7,444 words) - 06:21, 29 August 2013
- * Relative risk ratio63 KB (8,790 words) - 06:57, 2 March 2021
- ! Intervention!! [[Relative risk ratio]]20 KB (2,755 words) - 01:35, 14 September 2013